Harbor Capital Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.23M | Buy |
9,254
+183
| +2% | +$44.2K | 0.09% | 272 |
|
|
2025
Q1 | $2.21M | Buy |
9,071
+1,247
| +16% | +$304K | 0.1% | 268 |
|
|
2024
Q4 | $2.57M | Buy |
7,824
+321
| +4% | +$105K | 0.11% | 237 |
|
|
2024
Q3 | $2.51M | Buy |
7,503
+3,840
| +105% | +$1.28M | 0.11% | 255 |
|
|
2024
Q2 | $1M | Buy |
3,663
+2,792
| +321% | +$762K | 0.08% | 356 |
|
|
2024
Q1 | $301K | Buy |
+871
| New | +$301K | 0.04% | 521 |
|
|
2023
Q4 | – | Sell |
-1,110
| Closed | -$398K | – | 439 |
|
|
2023
Q3 | $398K | Sell |
1,110
-116
| -9% | -$41.6K | 0.09% | 258 |
|
|
2023
Q2 | $465K | Buy |
1,226
+3
| +0.2% | +$1.14K | 0.09% | 257 |
|
|
2023
Q1 | $586K | Sell |
1,223
-120
| -9% | -$57.5K | 0.17% | 123 |
|
|
2022
Q4 | $565K | Sell |
1,343
-29
| -2% | -$12.2K | 0.55% | 60 |
|
|
2022
Q3 | $572K | Sell |
1,372
-153
| -10% | -$63.8K | 0.53% | 60 |
|
|
2022
Q2 | $755K | Sell |
1,525
-34
| -2% | -$16.8K | 0.57% | 56 |
|
|
2022
Q1 | $878K | Buy |
1,559
+49
| +3% | +$27.6K | 0.41% | 66 |
|
|
2021
Q4 | $1.14M | Buy |
+1,510
| New | +$1.14M | 0.42% | 67 |
|